> top > docs > PMC:1064873 > spans > 16823-17327 > annotations

PMC:1064873 / 16823-17327 JSONTXT

Annnotations TAB JSON ListView MergeView

LappsTest

Id Subject Object Predicate Lexical cue
T12196 25-29 Protein denotes IL-2
T12201 474-479 Protein denotes IL-10
T12200 400-407 Protein denotes RA CD4+
T12199 173-177 Protein denotes IL-2
T12198 109-114 Protein denotes IL-10
T12197 44-48 Protein denotes CD4+

biosemtest

Id Subject Object Predicate Lexical cue
T12795 188-203 UMLS/C1819447 denotes was not affect
T12794 40-55 UMLS/C1819447 denotes by CD4+ T cell
T12785 86-90 UMLS/C1332709 denotes ion
T12780 337-345 UMLS/C2587213 denotes 13.7%;
T12779 167-175 UMLS/C2587213 denotes arly, IL
T12766 226-231 UMLS/C0439275 denotes RA pa
T12755 72-77 UMLS/C0231290 denotes D28 c
T12751 395-402 UMLS/C1546471 denotes that RA
T12748 86-90 UMLS/C1426202 denotes ion
T12743 208-211 UMLS/C1518422 denotes 1
T12742 337-345 UMLS/C0332298 denotes 13.7%;
T12741 167-175 UMLS/C0332298 denotes arly, IL
T12735 244-252 UMLS/C1705908 denotes ntage de
T12734 143-151 UMLS/C1705908 denotes healthy
T12719 395-402 UMLS/C0332294 denotes that RA
T12718 395-402 UMLS/C1274040 denotes that RA
T12706 265-273 UMLS/C0205216 denotes ± 13.8%)
T12704 254-264 UMLS/C0439165 denotes ease, -2.1
T12696 337-345 UMLS/C0243148 denotes 13.7%;
T12695 167-175 UMLS/C0243148 denotes arly, IL
T12680 244-252 UMLS/C1550655 denotes ntage de
T12679 143-151 UMLS/C1550655 denotes healthy
T12669 373-378 UMLS/C1515187 denotes hese
T12668 337-345 UMLS/C1547100 denotes 13.7%;
T12667 167-175 UMLS/C1547100 denotes arly, IL
T12648 112-120 UMLS/C0150312 denotes 10 in ac
T12643 78-81 UMLS/C2698592 denotes sti
T12639 5-8 UMLS/C0349966 denotes dit
T12635 133-139 UMLS/C1553875 denotes nts an
T12533 491-496 UMLS/C1334098 denotes activ
T12532 232-237 UMLS/C1334098 denotes ients
T12531 124-129 UMLS/C1334098 denotes RA p
T12515 254-264 UMLS/C1549488 denotes ease, -2.1
T12510 379-387 UMLS/C1883357 denotes esults i
T12509 337-345 UMLS/C0009932 denotes 13.7%;
T12508 167-175 UMLS/C0009932 denotes arly, IL
T12503 265-273 UMLS/C0547047 denotes ± 13.8%)
T12498 244-252 UMLS/C0030705 denotes ntage de
T12497 143-151 UMLS/C0030705 denotes healthy
T12493 112-120 UMLS/C0392148 denotes 10 in ac
T12483 212-220 UMLS/C1314939 denotes g/ml IL-
T12482 244-252 UMLS/C1578479 denotes ntage de
T12481 143-151 UMLS/C1578479 denotes healthy
T12476 244-252 UMLS/C1578483 denotes ntage de
T12475 143-151 UMLS/C1578483 denotes healthy
T12471 244-252 UMLS/C1578480 denotes ntage de
T12470 143-151 UMLS/C1578480 denotes healthy
T12466 244-252 UMLS/C1578481 denotes ntage de
T12465 143-151 UMLS/C1578481 denotes healthy
T12461 78-81 UMLS/C0108779 denotes sti
T12459 244-252 UMLS/C1578486 denotes ntage de
T12458 143-151 UMLS/C1578486 denotes healthy
T12454 244-252 UMLS/C1578484 denotes ntage de
T12453 143-151 UMLS/C1578484 denotes healthy
T12452 143-151 UMLS/C1578485 denotes healthy
T12448 254-264 UMLS/C1561533 denotes ease, -2.1
T12440 133-139 UMLS/C1561511 denotes nts an
T12437 244-252 UMLS/C1578485 denotes ntage de
T12432 403-411 UMLS/C1444656 denotes CD4+ T c
T12422 133-139 UMLS/C0205177 denotes nts an
T12407 133-139 UMLS/C2347179 denotes nts an
T12401 491-496 UMLS/C0085295 denotes activ
T12400 232-237 UMLS/C0085295 denotes ients
T12399 124-129 UMLS/C0085295 denotes RA p
T12385 318-325 UMLS/C0392756 denotes hy cont
T12384 265-273 UMLS/C0392756 denotes ± 13.8%)
T12378 457-459 UMLS/C0319022 denotes la
T12368 212-220 UMLS/C0392760 denotes g/ml IL-
T12364 10-12 UMLS/C1553634 denotes n,
T12362 133-139 UMLS/C1561512 denotes nts an
T12355 133-139 UMLS/C1561510 denotes nts an
T12354 133-139 UMLS/C1561513 denotes nts an
T12345 133-139 UMLS/C1561509 denotes nts an
T12339 133-139 UMLS/C1561508 denotes nts an
T12332 133-139 UMLS/C1561507 denotes nts an
T12319 133-139 UMLS/C1547419 denotes nts an
T12629 265-273 UMLS/C0442797 denotes ± 13.8%)
T12627 18-26 UMLS/C1883712 denotes mpared I
T12626 425-432 UMLS/C0039194 denotes ss susc
T12625 64-71 UMLS/C0039194 denotes D3 and
T12613 373-378 UMLS/C1883727 denotes hese
T12607 86-90 UMLS/C0075747 denotes ion
T12602 31-39 UMLS/C1707455 denotes roductio
T12598 337-345 UMLS/C1550141 denotes 13.7%;
T12597 167-175 UMLS/C1550141 denotes arly, IL
T12589 491-496 UMLS/C1149215 denotes activ
T12588 232-237 UMLS/C1149215 denotes ients
T12587 124-129 UMLS/C1149215 denotes RA p
T12575 10-12 UMLS/C0450353 denotes n,
T12563 481-487 UMLS/C2348382 denotes uring
T12560 445-456 UMLS/C0231204 denotes e immunoreg
T12555 395-402 UMLS/C1280519 denotes that RA
T12552 481-487 UMLS/C1280500 denotes uring
T12547 212-220 UMLS/C0001721 denotes g/ml IL-
T12546 72-77 UMLS/C0687676 denotes D28 c
T12544 491-496 UMLS/C1522550 denotes activ
T12543 232-237 UMLS/C1522550 denotes ients
T12542 124-129 UMLS/C1522550 denotes RA p
T12310 337-345 UMLS/C1882979 denotes 13.7%;
T12309 167-175 UMLS/C1882979 denotes arly, IL

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T13584 498-503 NN denotes phase
T13583 491-497 JJ denotes active
T13582 487-490 DT denotes the
T13581 480-486 IN denotes during
T13580 474-479 NN denotes IL-10
T13579 471-473 IN denotes of
T13578 464-470 NN denotes effect
T13577 447-463 JJ denotes immunoregulatory
T13576 443-446 DT denotes the
T13575 440-442 TO denotes to
T13574 428-439 JJ denotes susceptible
T13573 423-427 RB denotes less
T13572 416-422 VB denotes become
T13571 410-415 NN denotes cells
T13570 408-409 NN denotes T
T13569 403-407 JJ denotes CD4+
T13568 400-402 NN denotes RA
T13567 395-399 IN denotes that
T13566 386-394 VB denotes indicate
T13565 378-385 NN denotes results
T13564 372-377 DT denotes these
T13563 370-371 -COMMA- denotes ,
T13562 362-370 RB denotes together
T13561 356-361 VB denotes Taken
T13560 353-354 -RRB- denotes )
T13559 349-353 CD denotes 0.05
T13558 347-348 SYM denotes <
T13557 345-346 NN denotes P
T13556 343-344 -COLON- denotes ;
T13555 342-343 NN denotes %
T13554 338-342 CD denotes 13.7
T13553 336-337 SYM denotes ±
T13552 331-335 CD denotes 61.1
T13551 330-331 -LRB- denotes (
T13550 321-329 NN denotes controls
T13549 313-320 JJ denotes healthy
T13548 310-312 IN denotes in
T13547 302-309 VB denotes reduced
T13546 288-301 RB denotes significantly
T13545 284-287 VB denotes was
T13544 281-283 PRP denotes it
T13543 275-280 IN denotes while
T13542 273-274 -COMMA- denotes ,
T13541 272-273 -RRB- denotes )
T13540 271-272 NN denotes %
T13539 267-271 CD denotes 13.8
T13538 265-266 -COLON- denotes ±
T13537 260-264 CD denotes -2.1
T13536 258-259 -COMMA- denotes ,
T13535 250-258 NN denotes decrease
T13534 239-249 NN denotes percentage
T13533 238-239 -LRB- denotes (
T13532 229-237 NN denotes patients
T13531 226-228 NN denotes RA
T13530 223-225 IN denotes in
T13529 217-222 NN denotes IL-10
T13528 211-216 NN denotes ng/ml
T13527 209-210 CD denotes 1
T13526 206-208 IN denotes by
T13525 197-205 VB denotes affected
T13524 193-196 RB denotes not
T13523 189-192 VB denotes was
T13522 178-188 NN denotes production
T13521 173-177 NN denotes IL-2
T13520 171-172 -COMMA- denotes ,
T13519 162-171 RB denotes Similarly
T13518 152-160 NN denotes controls
T13517 144-151 JJ denotes healthy
T13516 141-143 IN denotes in
T13515 137-140 CC denotes and
T13514 128-136 NN denotes patients
T13513 125-127 NN denotes RA
T13512 118-124 JJ denotes active
T13511 115-117 IN denotes in
T13510 109-114 NN denotes IL-10
T13509 106-108 IN denotes of
T13508 97-105 NN denotes presence
T13507 93-96 DT denotes the
T13506 90-92 IN denotes in
T13505 76-89 NN denotes costimulation
T13504 71-75 NN denotes CD28
T13503 67-70 CC denotes and
T13502 63-66 NN denotes CD3
T13501 57-62 IN denotes after
T13500 51-56 NN denotes cells
T13499 49-50 NN denotes T
T13498 44-48 JJ denotes CD4+
T13497 41-43 IN denotes by
T13496 30-40 NN denotes production
T13495 25-29 NN denotes IL-2
T13494 16-24 VB denotes compared
T13493 13-15 PRP denotes we
T13492 11-12 -COMMA- denotes ,
T13491 3-11 NN denotes addition
T13490 0-2 IN denotes In
R6758 T13491 T13490 arg2Of addition,In
R6759 T13493 T13494 arg1Of we,compared
R6760 T13494 T13490 arg1Of compared,In
R6761 T13494 T13492 arg1Of compared,","
R6762 T13494 T13497 arg1Of compared,by
R6763 T13494 T13501 arg1Of compared,after
R6764 T13496 T13494 arg2Of production,compared
R6765 T13496 T13495 arg1Of production,IL-2
R6766 T13500 T13497 arg2Of cells,by
R6767 T13500 T13498 arg1Of cells,CD4+
R6768 T13500 T13499 arg1Of cells,T
R6769 T13502 T13503 arg1Of CD3,and
R6770 T13504 T13503 arg2Of CD28,and
R6771 T13505 T13501 arg2Of costimulation,after
R6772 T13505 T13502 arg1Of costimulation,CD3
R6773 T13505 T13504 arg1Of costimulation,CD28
R6774 T13505 T13506 arg1Of costimulation,in
R6775 T13505 T13516 arg1Of costimulation,in
R6776 T13506 T13515 arg1Of in,and
R6777 T13508 T13506 arg2Of presence,in
R6778 T13508 T13507 arg1Of presence,the
R6779 T13508 T13509 arg1Of presence,of
R6780 T13508 T13511 arg1Of presence,in
R6781 T13510 T13509 arg2Of IL-10,of
R6782 T13514 T13511 arg2Of patients,in
R6783 T13514 T13512 arg1Of patients,active
R6784 T13514 T13513 arg1Of patients,RA
R6785 T13516 T13515 arg2Of in,and
R6786 T13518 T13516 arg2Of controls,in
R6787 T13518 T13517 arg1Of controls,healthy
R6788 T13522 T13521 arg1Of production,IL-2
R6789 T13522 T13523 arg1Of production,was
R6790 T13522 T13525 arg2Of production,affected
R6791 T13525 T13519 arg1Of affected,Similarly
R6792 T13525 T13520 arg1Of affected,","
R6793 T13525 T13523 arg2Of affected,was
R6794 T13525 T13524 arg1Of affected,not
R6795 T13525 T13542 arg1Of affected,","
R6796 T13525 T13543 arg1Of affected,while
R6797 T13527 T13528 arg1Of 1,ng/ml
R6798 T13529 T13525 arg1Of IL-10,affected
R6799 T13529 T13526 arg2Of IL-10,by
R6800 T13529 T13527 arg1Of IL-10,1
R6801 T13529 T13530 arg1Of IL-10,in
R6802 T13532 T13530 arg2Of patients,in
R6803 T13532 T13531 arg1Of patients,RA
R6804 T13532 T13533 arg1Of patients,(
R6805 T13535 T13533 arg2Of decrease,(
R6806 T13535 T13534 arg1Of decrease,percentage
R6807 T13535 T13536 arg1Of decrease,","
R6808 T13540 T13536 arg2Of %,","
R6809 T13540 T13537 arg1Of %,-2.1
R6810 T13540 T13538 arg1Of %,±
R6811 T13540 T13539 arg1Of %,13.8
R6812 T13541 T13533 arg3Of ),(
R6813 T13544 T13545 arg1Of it,was
R6814 T13544 T13547 arg2Of it,reduced
R6815 T13547 T13543 arg2Of reduced,while
R6816 T13547 T13545 arg2Of reduced,was
R6817 T13547 T13546 arg1Of reduced,significantly
R6818 T13547 T13548 arg1Of reduced,in
R6819 T13547 T13551 arg1Of reduced,(
R6820 T13550 T13548 arg2Of controls,in
R6821 T13550 T13549 arg1Of controls,healthy
R6822 T13554 T13553 arg1Of 13.7,±
R6823 T13555 T13551 arg2Of %,(
R6824 T13555 T13552 arg1Of %,61.1
R6825 T13555 T13554 arg1Of %,13.7
R6826 T13555 T13556 arg1Of %,;
R6827 T13557 T13556 arg2Of P,;
R6828 T13557 T13558 arg1Of P,<
R6829 T13557 T13559 arg1Of P,0.05
R6830 T13560 T13551 arg3Of ),(
R6831 T13561 T13562 arg1Of Taken,together
R6832 T13565 T13564 arg1Of results,these
R6833 T13565 T13566 arg1Of results,indicate
R6834 T13566 T13561 modOf indicate,Taken
R6835 T13566 T13563 arg1Of indicate,","
R6836 T13571 T13568 arg1Of cells,RA
R6837 T13571 T13569 arg1Of cells,CD4+
R6838 T13571 T13570 arg1Of cells,T
R6839 T13571 T13572 arg1Of cells,become
R6840 T13571 T13574 arg1Of cells,susceptible
R6841 T13572 T13566 arg2Of become,indicate
R6842 T13572 T13567 arg1Of become,that
R6843 T13572 T13581 arg1Of become,during
R6844 T13574 T13572 arg2Of susceptible,become
R6845 T13574 T13573 arg1Of susceptible,less
R6846 T13574 T13575 arg1Of susceptible,to
R6847 T13578 T13575 arg2Of effect,to
R6848 T13578 T13576 arg1Of effect,the
R6849 T13578 T13577 arg1Of effect,immunoregulatory
R6850 T13578 T13579 arg1Of effect,of
R6851 T13580 T13579 arg2Of IL-10,of
R6852 T13584 T13581 arg2Of phase,during
R6853 T13584 T13582 arg1Of phase,the
R6854 T13584 T13583 arg1Of phase,active

bionlp-st-ge-2016-test-proteins

Id Subject Object Predicate Lexical cue
T12929 474-479 Protein denotes IL-10
T12928 403-406 Protein denotes CD4
T12927 217-222 Protein denotes IL-10
T12926 173-177 Protein denotes IL-2
T12925 109-114 Protein denotes IL-10
T12924 71-75 Protein denotes CD28
T12923 44-47 Protein denotes CD4
T12922 25-29 Protein denotes IL-2

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T13115 173-177 http://www.uniprot.org/uniprot/P60568 denotes IL-2
T13114 25-29 http://www.uniprot.org/uniprot/P60568 denotes IL-2
T13113 63-66 http://www.uniprot.org/uniprot/P09693 denotes CD3
T13110 63-66 http://www.uniprot.org/uniprot/P07766 denotes CD3
T13107 63-66 http://www.uniprot.org/uniprot/P04234 denotes CD3
T13104 63-66 http://www.uniprot.org/uniprot/P20963 denotes CD3
T13101 71-75 http://www.uniprot.org/uniprot/P10747 denotes CD28
T13096 403-406 http://www.uniprot.org/uniprot/P01730 denotes CD4
T13095 44-47 http://www.uniprot.org/uniprot/P01730 denotes CD4
T13078 474-479 http://www.uniprot.org/uniprot/P22301 denotes IL-10
T13077 217-222 http://www.uniprot.org/uniprot/P22301 denotes IL-10
T13076 109-114 http://www.uniprot.org/uniprot/P22301 denotes IL-10

GO-BP

Id Subject Object Predicate Lexical cue
T12824 173-188 http://purl.obolibrary.org/obo/GO_0032663 denotes IL-2 production
T12823 25-40 http://purl.obolibrary.org/obo/GO_0032663 denotes IL-2 production
T12822 173-188 http://purl.obolibrary.org/obo/GO_0032623 denotes IL-2 production
T12821 25-40 http://purl.obolibrary.org/obo/GO_0032623 denotes IL-2 production

GO-CC

Id Subject Object Predicate Lexical cue
T12960 410-415 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T12959 51-56 http://purl.obolibrary.org/obo/GO_0005623 denotes cells

GO-MF

Id Subject Object Predicate Lexical cue
T12950 173-177 http://purl.obolibrary.org/obo/GO_0005134 denotes IL-2
T12949 25-29 http://purl.obolibrary.org/obo/GO_0005134 denotes IL-2
T12943 474-479 http://purl.obolibrary.org/obo/GO_0005141 denotes IL-10
T12942 217-222 http://purl.obolibrary.org/obo/GO_0005141 denotes IL-10
T12941 109-114 http://purl.obolibrary.org/obo/GO_0005141 denotes IL-10

sentences

Id Subject Object Predicate Lexical cue
T12806 356-504 Sentence denotes Taken together, these results indicate that RA CD4+ T cells become less susceptible to the immunoregulatory effect of IL-10 during the active phase.
T12805 162-355 Sentence denotes Similarly, IL-2 production was not affected by 1 ng/ml IL-10 in RA patients (percentage decrease, -2.1 ± 13.8%), while it was significantly reduced in healthy controls (61.1 ± 13.7%; P < 0.05).
T12804 0-161 Sentence denotes In addition, we compared IL-2 production by CD4+ T cells after CD3 and CD28 costimulation in the presence of IL-10 in active RA patients and in healthy controls.
T100 0-161 Sentence denotes In addition, we compared IL-2 production by CD4+ T cells after CD3 and CD28 costimulation in the presence of IL-10 in active RA patients and in healthy controls.
T101 162-355 Sentence denotes Similarly, IL-2 production was not affected by 1 ng/ml IL-10 in RA patients (percentage decrease, -2.1 ± 13.8%), while it was significantly reduced in healthy controls (61.1 ± 13.7%; P < 0.05).
T102 356-504 Sentence denotes Taken together, these results indicate that RA CD4+ T cells become less susceptible to the immunoregulatory effect of IL-10 during the active phase.

simple1

Id Subject Object Predicate Lexical cue
T13156 474-479 Protein denotes IL-10
T13155 403-406 Protein denotes CD4
T13154 217-222 Protein denotes IL-10
T13153 173-177 Protein denotes IL-2
T13152 109-114 Protein denotes IL-10
T13151 71-75 Protein denotes CD28
T13150 44-47 Protein denotes CD4
T13149 25-29 Protein denotes IL-2

BioNLP16_DUT

Id Subject Object Predicate Lexical cue
T14405 178-188 Gene_expression denotes production
T14404 197-205 Regulation denotes affected
T14403 30-40 Gene_expression denotes production
T14391 474-479 Protein denotes IL-10
T14390 403-406 Protein denotes CD4
T14389 217-222 Protein denotes IL-10
T14388 173-177 Protein denotes IL-2
T14387 109-114 Protein denotes IL-10
T14386 71-75 Protein denotes CD28
T14385 44-47 Protein denotes CD4
T14384 25-29 Protein denotes IL-2
R7418 T14384 T14403 themeOf IL-2,production
R7419 T14388 T14405 themeOf IL-2,production
R7423 T14405 T14404 themeOf production,affected

BioNLP16_Messiy

Id Subject Object Predicate Lexical cue
T13642 302-309 Negative_regulation denotes reduced
T13641 197-205 Regulation denotes affected
T13640 178-188 Gene_expression denotes production
T13639 30-40 Gene_expression denotes production
T13625 474-479 Protein denotes IL-10
T13624 403-406 Protein denotes CD4
T13623 217-222 Protein denotes IL-10
T13622 173-177 Protein denotes IL-2
T13621 109-114 Protein denotes IL-10
T13620 71-75 Protein denotes CD28
T13619 44-47 Protein denotes CD4
T13618 25-29 Protein denotes IL-2
R6866 T13618 T13639 themeOf IL-2,production
R6867 T13622 T13640 themeOf IL-2,production
R6871 T13640 T13642 themeOf production,reduced
R6872 T13640 T13641 themeOf production,affected

DLUT931

Id Subject Object Predicate Lexical cue
T14154 197-205 Regulation denotes affected
T14153 178-188 Gene_expression denotes production
T14152 30-40 Gene_expression denotes production
T14132 474-479 Protein denotes IL-10
T14131 403-406 Protein denotes CD4
T14130 217-222 Protein denotes IL-10
T14129 173-177 Protein denotes IL-2
T14128 109-114 Protein denotes IL-10
T14127 71-75 Protein denotes CD28
T14126 44-47 Protein denotes CD4
T14125 25-29 Protein denotes IL-2
R7341 T14125 T14152 themeOf IL-2,production
R7342 T14129 T14153 themeOf IL-2,production
R7343 T14130 T14154 causeOf IL-10,affected
R7354 T14153 T14154 themeOf production,affected

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue Negation
T14347 173-259 Regulation denotes IL-2 production was not affected by 1 ng/ml IL-10 in RA patients (percentage decrease, true
T14345 173-188 Gene_expression denotes IL-2 production
T14344 0-89 Gene_expression denotes In addition, we compared IL-2 production by CD4+ T cells after CD3 and CD28 costimulation
T14343 71-89 Positive_regulation denotes CD28 costimulation
T14292 471-479 Protein denotes of IL-10
T14289 125-127 Protein denotes RA
T14284 400-415 Entity denotes RA CD4+ T cells
T14282 400-402 Protein denotes RA
T14280 71-75 Protein denotes CD28
T14275 63-66 Protein denotes CD3
T14331 206-222 Protein denotes by 1 ng/ml IL-10
T14317 226-228 Protein denotes RA
T14311 331-348 Entity denotes 61.1 ± 13.7%; P <
T14310 41-89 Entity denotes by CD4+ T cells after CD3 and CD28 costimulation
T14307 173-177 Protein denotes IL-2
T14303 25-29 Protein denotes IL-2
T14300 109-160 Protein denotes IL-10 in active RA patients and in healthy controls
R7393 T14280 T14343 themeOf CD28,CD28 costimulation
R7397 T14303 T14344 themeOf IL-2,"In addition, we compared IL-2 production by CD4+ T cells after CD3 and CD28 costimulation"
R7399 T14307 T14345 themeOf IL-2,IL-2 production
R7403 T14331 T14347 causeOf by 1 ng/ml IL-10,"IL-2 production was not affected by 1 ng/ml IL-10 in RA patients (percentage decrease,"
R7407 T14345 T14347 themeOf IL-2 production,"IL-2 production was not affected by 1 ng/ml IL-10 in RA patients (percentage decrease,"

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T14091 503-504 . denotes .
T14090 498-503 NN denotes phase
T14089 491-497 JJ denotes active
T14088 487-490 DT denotes the
T14087 480-486 IN denotes during
T14086 474-479 NN denotes IL-10
T14085 471-473 IN denotes of
T14084 464-470 NN denotes effect
T14083 447-463 JJ denotes immunoregulatory
T14082 443-446 DT denotes the
T14081 440-442 TO denotes to
T14080 428-439 JJ denotes susceptible
T14079 423-427 RBR denotes less
T14078 416-422 VBP denotes become
T14077 410-415 NNS denotes cells
T14076 408-409 NNP denotes T
T14075 406-407 VBD denotes +
T14074 403-406 NNP denotes CD4
T14073 400-402 NNP denotes RA
T14072 395-399 IN denotes that
T14071 386-394 VBP denotes indicate
T14070 378-385 NNS denotes results
T14069 372-377 DT denotes these
T14068 370-371 , denotes ,
T14067 362-370 RB denotes together
T14066 356-361 VBN denotes Taken
T14065 354-355 . denotes .
T14064 353-354 -RRB- denotes )
T14063 349-353 CD denotes 0.05
T14062 347-348 NNP denotes <
T14061 345-346 NNP denotes P
T14060 343-344 : denotes ;
T14059 342-343 NN denotes %
T14058 338-342 CD denotes 13.7
T14057 336-337 CD denotes ±
T14056 331-335 CD denotes 61.1
T14055 330-331 -LRB- denotes (
T14054 321-329 NNS denotes controls
T14053 313-320 JJ denotes healthy
T14052 310-312 IN denotes in
T14051 302-309 VBN denotes reduced
T14050 288-301 RB denotes significantly
T14049 284-287 VBD denotes was
T14048 281-283 PRP denotes it
T14047 275-280 IN denotes while
T14046 273-274 , denotes ,
T14045 272-273 -RRB- denotes )
T14044 271-272 NN denotes %
T14043 267-271 CD denotes 13.8
T14042 265-266 NN denotes ±
T14041 260-264 CD denotes -2.1
T14040 258-259 , denotes ,
T14039 250-258 NN denotes decrease
T14038 239-249 NN denotes percentage
T14037 238-239 -LRB- denotes (
T14036 229-237 NNS denotes patients
T14035 226-228 NNP denotes RA
T14034 223-225 IN denotes in
T14033 217-222 NN denotes IL-10
T14032 211-216 NN denotes ng/ml
T14031 209-210 CD denotes 1
T14030 206-208 IN denotes by
T14029 197-205 VBN denotes affected
T14028 193-196 RB denotes not
T14027 189-192 VBD denotes was
T14026 178-188 NN denotes production
T14025 173-177 JJ denotes IL-2
T14024 171-172 , denotes ,
T14023 162-171 RB denotes Similarly
T14022 160-161 . denotes .
T14021 152-160 NNS denotes controls
T14020 144-151 JJ denotes healthy
T14019 141-143 IN denotes in
T14018 137-140 CC denotes and
T14017 128-136 NNS denotes patients
T14016 125-127 NNP denotes RA
T14015 118-124 JJ denotes active
T14014 115-117 IN denotes in
T14013 109-114 NN denotes IL-10
T14012 106-108 IN denotes of
T14011 97-105 NN denotes presence
T14010 93-96 DT denotes the
T14009 90-92 IN denotes in
T14008 76-89 NN denotes costimulation
T14007 71-75 NNP denotes CD28
T14006 67-70 CC denotes and
T14005 63-66 NNP denotes CD3
T14004 57-62 IN denotes after
T14003 51-56 NNS denotes cells
T14002 49-50 NNP denotes T
T14001 47-48 NNP denotes +
T14000 44-47 NNP denotes CD4
T13999 41-43 IN denotes by
T13998 30-40 NN denotes production
T13997 25-29 JJ denotes IL-2
T13996 16-24 VBD denotes compared
T13995 13-15 PRP denotes we
T13994 11-12 , denotes ,
T13993 3-11 NN denotes addition
T13992 0-2 IN denotes In
R7222 T13992 T13996 prep In,compared
R7223 T13993 T13992 pobj addition,In
R7224 T13994 T13996 punct ",",compared
R7225 T13995 T13996 nsubj we,compared
R7226 T13996 T13996 ROOT compared,compared
R7227 T13997 T13998 compound IL-2,production
R7228 T13998 T13996 dobj production,compared
R7229 T13999 T13998 prep by,production
R7230 T14000 T14003 compound CD4,cells
R7231 T14001 T14003 compound +,cells
R7232 T14002 T14003 compound T,cells
R7233 T14003 T13999 pobj cells,by
R7234 T14004 T13996 prep after,compared
R7235 T14005 T14008 nsubj CD3,costimulation
R7236 T14006 T14005 cc and,CD3
R7237 T14007 T14005 conj CD28,CD3
R7238 T14008 T14004 pobj costimulation,after
R7239 T14009 T14008 prep in,costimulation
R7240 T14010 T14011 det the,presence
R7241 T14011 T14009 pobj presence,in
R7242 T14012 T14011 prep of,presence
R7243 T14013 T14012 pobj IL-10,of
R7244 T14014 T14013 prep in,IL-10
R7245 T14015 T14017 amod active,patients
R7246 T14016 T14017 compound RA,patients
R7247 T14017 T14014 pobj patients,in
R7248 T14018 T14014 cc and,in
R7249 T14019 T14014 conj in,in
R7250 T14020 T14021 amod healthy,controls
R7251 T14021 T14019 pobj controls,in
R7252 T14022 T13996 punct .,compared
R7253 T14023 T14029 advmod Similarly,affected
R7254 T14024 T14029 punct ",",affected
R7255 T14025 T14026 compound IL-2,production
R7256 T14026 T14029 nsubjpass production,affected
R7257 T14027 T14029 auxpass was,affected
R7258 T14028 T14029 neg not,affected
R7259 T14029 T14029 ROOT affected,affected
R7260 T14030 T14029 agent by,affected
R7261 T14031 T14033 nummod 1,IL-10
R7262 T14032 T14033 compound ng/ml,IL-10
R7263 T14033 T14030 pobj IL-10,by
R7264 T14034 T14033 prep in,IL-10
R7265 T14035 T14036 compound RA,patients
R7266 T14036 T14034 pobj patients,in
R7267 T14037 T14039 punct (,decrease
R7268 T14038 T14039 compound percentage,decrease
R7269 T14039 T14033 appos decrease,IL-10
R7270 T14040 T14039 punct ",",decrease
R7271 T14041 T14042 nummod -2.1,±
R7272 T14042 T14039 appos ±,decrease
R7273 T14043 T14044 nummod 13.8,%
R7274 T14044 T14042 appos %,±
R7275 T14045 T14042 punct ),±
R7276 T14046 T14029 punct ",",affected
R7277 T14047 T14051 mark while,reduced
R7278 T14048 T14051 nsubjpass it,reduced
R7279 T14049 T14051 auxpass was,reduced
R7280 T14050 T14051 advmod significantly,reduced
R7281 T14051 T14029 advcl reduced,affected
R7282 T14052 T14051 prep in,reduced
R7283 T14053 T14054 amod healthy,controls
R7284 T14054 T14052 pobj controls,in
R7285 T14055 T14057 punct (,±
R7286 T14056 T14057 nummod 61.1,±
R7287 T14057 T14029 dep ±,affected
R7288 T14058 T14059 nummod 13.7,%
R7289 T14059 T14057 appos %,±
R7290 T14060 T14062 punct ;,<
R7291 T14061 T14062 compound P,<
R7292 T14062 T14057 appos <,±
R7293 T14063 T14062 nummod 0.05,<
R7294 T14064 T14062 punct ),<
R7295 T14065 T14029 punct .,affected
R7296 T14066 T14071 advcl Taken,indicate
R7297 T14067 T14066 advmod together,Taken
R7298 T14068 T14071 punct ",",indicate
R7299 T14069 T14070 det these,results
R7300 T14070 T14071 nsubj results,indicate
R7301 T14071 T14071 ROOT indicate,indicate
R7302 T14072 T14078 mark that,become
R7303 T14073 T14074 compound RA,CD4
R7304 T14074 T14078 nsubj CD4,become
R7305 T14075 T14077 amod +,cells
R7306 T14076 T14077 compound T,cells
R7307 T14077 T14078 nsubj cells,become
R7308 T14078 T14071 ccomp become,indicate
R7309 T14079 T14080 advmod less,susceptible
R7310 T14080 T14078 acomp susceptible,become
R7311 T14081 T14080 prep to,susceptible
R7312 T14082 T14084 det the,effect
R7313 T14083 T14084 amod immunoregulatory,effect
R7314 T14084 T14081 pobj effect,to
R7315 T14085 T14084 prep of,effect
R7316 T14086 T14085 pobj IL-10,of
R7317 T14087 T14084 prep during,effect
R7318 T14088 T14090 det the,phase
R7319 T14089 T14090 amod active,phase
R7320 T14090 T14087 pobj phase,during
R7321 T14091 T14071 punct .,indicate

bionlp-st-ge-2016-test-tees

Id Subject Object Predicate Lexical cue
T13064 474-479 Protein denotes IL-10
T13063 403-406 Protein denotes CD4
T13062 197-205 Regulation denotes affected
T13061 178-188 Gene_expression denotes production
T13060 173-177 Protein denotes IL-2
T13059 109-114 Protein denotes IL-10
T13058 71-75 Protein denotes CD28
T13057 63-66 Protein denotes CD3
T13056 44-48 Protein denotes CD4+
R6413 T13060 T13061 themeOf IL-2,production
R6414 T13061 T13062 themeOf production,affected

test3

Id Subject Object Predicate Lexical cue
T12304 474-479 Protein denotes IL-10
T12303 464-470 Regulation denotes effect
T12302 403-406 Protein denotes CD4
T12301 302-309 Negative_regulation denotes reduced
T12300 250-258 Negative_regulation denotes decrease
T12299 217-222 Protein denotes IL-10
T12298 197-205 Regulation denotes affected
T12297 178-188 Gene_expression denotes production
T12296 173-177 Protein denotes IL-2
T12295 109-114 Protein denotes IL-10
T12294 71-75 Protein denotes CD28
T12293 44-47 Protein denotes CD4
T12292 30-40 Gene_expression denotes production
T12291 25-29 Protein denotes IL-2
T12242 474-479 Protein denotes IL-10
T12241 403-406 Protein denotes CD4
T12240 217-222 Protein denotes IL-10
T12239 173-177 Protein denotes IL-2
T12238 109-114 Protein denotes IL-10
T12237 71-75 Protein denotes CD28
T12236 44-47 Protein denotes CD4
T12235 25-29 Protein denotes IL-2
R6350 T12291 T12292 themeOf IL-2,production
R6351 T12296 T12297 themeOf IL-2,production
R6352 T12297 T12300 themeOf production,decrease
R6353 T12297 T12301 themeOf production,reduced
R6354 T12297 T12298 themeOf production,affected
R6355 T12298 T12301 themeOf affected,reduced
R6356 T12299 T12298 causeOf IL-10,affected
R6357 T12300 T12298 causeOf decrease,affected
R6358 T12304 T12303 causeOf IL-10,effect

testone

Id Subject Object Predicate Lexical cue
T12174 464-470 Regulation denotes effect
T12173 302-309 Negative_regulation denotes reduced
T12172 250-258 Negative_regulation denotes decrease
T12171 197-205 Regulation denotes affected
T12170 178-188 Gene_expression denotes production
T12169 30-40 Gene_expression denotes production
T12153 474-479 Protein denotes IL-10
T12152 403-406 Protein denotes CD4
T12151 217-222 Protein denotes IL-10
T12150 173-177 Protein denotes IL-2
T12149 109-114 Protein denotes IL-10
T12148 71-75 Protein denotes CD28
T12147 44-47 Protein denotes CD4
T12146 25-29 Protein denotes IL-2
R6317 T12146 T12169 themeOf IL-2,production
R6318 T12150 T12170 themeOf IL-2,production
R6319 T12151 T12171 causeOf IL-10,affected
R6320 T12153 T12174 themeOf IL-10,effect
R6326 T12170 T12172 themeOf production,decrease
R6327 T12170 T12173 themeOf production,reduced
R6328 T12170 T12171 themeOf production,affected
R6329 T12172 T12171 causeOf decrease,affected